Michael F. Dubin - Jul 26, 2021 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Stock symbol
VRPX
Transactions as of
Jul 26, 2021
Transactions value $
$0
Form type
4
Date filed
8/5/2021, 06:11 PM
Next filing
Jan 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +20.2K $0.00 20.2K Jul 26, 2021 Common Stock, par value $0.00001 per share 20.2K $4.32 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.